Advances in our understanding of autoimmunity and tumour immunity have led to improvements in immunotherapy for these diseases. Ironically, effective tumour immunity requires the induction of the ...

Studies performed during the past 2 years have provided a deeper understanding into the role of CTLA-4, which is expressed on regulatory T cells, in preventing autoimmunity, and also provide ...

How could checkpoint inhibitors, a drug that traditionally stimulates the immune system, benefit people with autoimmunity? Autoimmune diseases arise when overactive immune cells mistakenly attack ...

Treatment and management of autoimmune diseases focus on controlling symptoms, modulating the immune response, and addressing ...

Igm Biosciences ( (IGMS) ) has released its Q3 earnings. Here is a breakdown of the information Igm Biosciences presented to its investors. IGM ...

Fate Therapeutics (NASDAQ:FATE) stock rallied 37% Monday after the company reported that the first patient in the Phase 1 ...

With a focus on cancer and autoimmune conditions, UBS has launched its coverage of 13 small and mid-cap biotechs, noting that stocks with competitive advantages, such as best-in-class or first-in ...

reducing Treg cells that are crucial for maintaining immune tolerance and for the control of inflammation and autoimmunity. Most autoimmune and inflammatory diseases exhibit disturbances in Treg ...